![]() |
About Us |
Management TeamFounder, CEO
Experience includes: founder and CEO of ISCHEM Corporation that has automated MRI for detection of “vulnerable” plaque for the heart disease and stroke market. He is first author of the core patent application for ISCHEM. Michael Willoughby, Ph.D., CFA Chief Financial Officer
Previous experience: previous financial oversight of an MRI automation project. Alex W. “Pete” Hart Consultant
Previous experience: CEO of Advanta Corporation and MasterCard International. He presently is Chairman of the Board of Silicon Valley Bancshares and US Encode Corporation as well as on the Board of Sanchez Computer Associates, Global Payments, Inc., and FairIsaac Corporation and GeoTrust. He also serves as an advisor to many companies. Gia Honnen Weisdorn, JD, LLM, MBA Corporate Counsel
Previous experience: counseling corporations at every stage of development and the oversight of intellectual property. Russell W. Anderson, Ph.D. Vice President of Operations & CTO
Previous experience: successful automation of the detection of “vulnerable” vascular plaque using MRI. This is a sub class of vascular plaque that causes heart attacks and strokes. Charles Hahm Project Manager
Previous experience: Successful management of detection of "vulnerable" vascular plaque using fMRI. Evelyn H. McConathy Patent Lawyer
Joel S. Lisker, JD Marketing and Sales Liaison for the Federal Government
Previous experience: Chief Counsel and Staff Director of the US Senate’s Committee on the Judiciary Sub-Committee on Security and Terrorism, FBI Special Agent, and the Senior Vice President for Security and Risk Management for MasterCard International. |
|
©No Lie MRI, 2006. All rights reserved. Site design by Good Cause Communications.
|

